Portfolio company
Komo Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech firm provides precision genome engineering technology and cell lines to therapeutic developers, biologics manufacturers, and agricultural biotechnology companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rewrite Therapeutics
This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.
Kodikaz Therapeutic Solutions
This deep-tech company develops a non-viral delivery platform for cell-specific gene therapies to treat cancer patients.
Cartography Biosciences
This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.
A-Alpha Bio
This deep-tech company provides protein interaction data and predictive models to pharmaceutical firms for the discovery and engineering of new medicines.
EditForce
This deep-tech firm develops RNA editing tools and therapies for pharmaceutical, industrial, and agricultural organisations to treat diseases and manipulate genes.
ParcelBio
This deep-tech firm develops mRNA delivery technologies and programmable medicines for biotechnology and pharmaceutical organisations to treat autoimmune diseases and oncology.
Granza Bio
This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.
GC Therapeutics
This deep-tech company develops a cell programming platform to produce off-the-shelf medicines for patients with gastrointestinal, neurological and immunological diseases.
